After a few hectic days of controversy over the alleged
presence of genetically modified organisms in wheat grown in a
field at Oregon, the agricultural chemicals provider,
), can finally look forward to some good news coming its way.
Monsanto's proprietary, Intacta RR2 Pro, has finally received
the pending regulatory approvals for production in Brazil. The
company intends to offer the technology for sale to be used in
the next crop planting season. With the help of Intacta RR2 Pro,
farmers will be able to improve their soybean production in three
ways - increasing yield, reducing pest attacks on the crop and
increasing tolerance to glyphosate herbicide.
Moreover, Monsanto announced positive outcomes in its latest
year of Ground Breakers, in the on-farm trials in Brazil. The
results represented a higher yield of soybeans. Monsanto expects
to test the invention on the farms of Argentina in fiscal 2014,
with an expected commercial launch in fiscal 2015.
In addition to this, Monsanto achieved yet another
break-through in China with the approval of the biotechnology
trait in Genuity DroughtGard Hybrids. In 2013, the farms in the
Western Great Plains were allowed to use the trait under
stewardship agreements, which allowed the trait to be used only
on-farm or for sale in the domestic market only. With the
approval from China, farmers will be in a better position to
produce more with the increased yield, for the international
markets as well.
The Genuity DroughtGard Hybrids is designed in a way to make
the corn plants use less water, leaving moisture in the soil,
which can be utilized in low water levels. This technology can
prove to be a major success in the ever changing climatic
We expect these developments to bring about great success to
the company as well as the U.S. grain production and exports.
Monsanto currently carries a Zacks Rank #3 (Hold). Other
stocks worth a look in the agricultural chemicals industry are
American Vanguard Corp.
) carrying a Zacks Rank #1 (Strong Buy), and
), each carrying a Zacks Rank #2 (Buy).
AMER VANGUARD (AVD): Free Stock Analysis
COSAN LTD-A (CZZ): Free Stock Analysis Report
LIMONEIRA CO (LMNR): Free Stock Analysis
MONSANTO CO-NEW (MON): Free Stock Analysis
To read this article on Zacks.com click here.